ArticleTravel medicine and infectious disease
COVID-19 vaccination campaign in Nepal, emerging UK variant and futuristic vaccination strategies to combat the ongoing pandemic.
Article in Travel medicine and infectious disease. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- General publics' perception toward COVID-19 vaccines in Afghanistan, 2021.Human vaccines & immunotherapeutics · 2023Article
- Predicting onset risk of COVID-19 symptom to support healthy travel route planning in the new normal of long-term coexistence with SARS-CoV-2.Environment and planning. B, urban analytics and city science · 2023Article
- Management of COVID-19 and vaccination in Nepal: A qualitative study.Health expectations : an international journal of public participation in health care and health policy · 2023Article
- Effect of religious fatalism and concern about new variants on the acceptance of COVID-19 vaccines.Frontiers in psychiatry · 2023Article
- Variant-specific RT-qPCR for rapid screening of B.1.617 mutations in SARS-CoV-2.The Libyan journal of medicine · 2022Article
- How an Outbreak of COVID-19 Circulated Widely in Nepal: A Chronological Analysis of the National Response to an Unprecedented Pandemic.Life (Basel, Switzerland) · 2022Review
- Computational studies on potential new anti-Covid-19 agents with a multi-target mode of action.Journal of King Saud University. Science · 2022Article
- Medical laboratory staff satisfaction and their perspective on the role of health institutions to combat COVID-19 pandemic.The Journal of international medical research · 2022Article
- Factors influencing the acceptability of COVID-19 vaccination: A cross-sectional study from Malaysia.Vacunas · 2022Article
- Perceived COVID-19 vaccine effectiveness, acceptance, and drivers of vaccination decision-making among the general adult population: A global survey of 20 countries.PLoS neglected tropical diseases · 2022Article
- Repurposing benzimidazole and benzothiazole derivatives as potential inhibitors of SARS-CoV-2: DFT, QSAR, molecular docking, molecular dynamics simulation, andJournal of King Saud University. Science · 2021Article
- The second wave of COVID-19 hits Nepal: Burden for Nepal's healthcare system.Health science reports · 2021Article
- Clinical features and laboratory findings first case of B. 1.617.2 (delta) variant concern (VOC) in Iraq.Annals of medicine and surgery (2012) · 2021Article
- Limited capacity of SARS-CoV-2 variants testing in Japan: A secondary analysis using publicly available data.Travel medicine and infectious diseaseArticle
- Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
With the emergence of the new variants of concern (VOC) of the SARS-CoV-2, the efficacy of certain vaccines against them requires further research and considerations for future scenarios of COVID-19 vaccination. The vaccines' lack of efficacy against VOC will pose at risk to the vaccinated population and is a public health threat. In this commentary, we discuss Nepal's recent experiences and expectations regarding the confirmation of VOC B.1.1.7 from the United Kingdom in the country.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.